293 Lesmill Road
6 articles with Conavi Medical
Conavi Medical Inc. and Sunnybrook Health Sciences Centre, announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.
Conavi Medical Announces Health Canada Approval of Novasight Hybrid System for Visualization During Coronary Angioplasty Procedures
Recent randomized studies with existing IVUS systems have shown that intravascular imaging has the potential to significantly improve clinical outcomes during angioplasty and stenting.
Conavi Medical Announces Clinical Use of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound and Optical Coherence Tomography Capabilities
Conavi Medical is pleased to announce the first clinical use of the NovasightHybrid System, which enables simultaneous imaging of coronary arteries with both intravascular ultrasound and Optical Coherence Tomography.
Conavi Medical Announces FDA 510(k) Clearance of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) Capabilities
ConaviTM Medical Inc. (www.conavi.com) is pleased to announce that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its NovasightTM Hybrid System
Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in China
China Grand Pharmaceutical and Healthcare Holdings will serve as the exclusive distributor of its Foresight Intracardiac Echocardiography and Novasight Hybrid Intravascular Imaging systems in China, Hong Kong, Taiwan and Macau.